Moxifloxacin in Treatment of Lower Respiratory Tract Infection:Clinical Trials / 中华医院感染学杂志
Chinese Journal of Nosocomiology
;
(24)2005.
Artículo
en Chino
| WPRIM
| ID: wpr-590272
ABSTRACT
OBJECTIVE To evaluate the efficacy and safety of moxifloxacin in treating lower respiratory infection.METHODS Totally 102 patients were enrolled in this study,but 3 cases were infixed or weeded.Fifty cases of trial group were given 400mg of moxifloxacin intravenously,once a day for 7-14 days,49 cases of control group were given 400mg of levofloxacin intravenously,once a day for 7-14 days.RESULTS The clinical efficacious rates of moxifloxacin and levofloxacin were 94.0% and 79.6%,respectively.The bacterial clearance rates of moxifloxacin and levofloxacin were 94.3% and 77.8%,respectively.There was significant difference(P0.05) between two groups.CONCLUSIONS Moxifloxacin injection is an effective and safe antibiotics for the treatment of lower respiratory tract infection.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Nosocomiology
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS